Home › GSK ORD 31 1/4P › Nieuws › 23andMe, GlaxoSmithKline deal raising concerns over privacy GSK ORD 31 1/4P OverzichtKoersenGrafiekSignalenNieuwsAnalysesWarrantsProfielWall - GBX (-) - 15 min. vertraagde - London Stock Exchange Open: - Verschil: - Volume: - Laag: - Hoog: - Hoog - Laag: - Type: Aandelen Ticker: GSK ISIN: GB00BN7SWP63 Overzicht Koersen Grafiek Signalen Nieuws Analyses Warrants Profiel Wall 23andMe, GlaxoSmithKline deal raising concerns over privacy 0 194 Fox News medical correspondent Dr. Marc Siegel on the promising signs in Biogen's Alzheimer's new treatment, GlaxoSmithKline buying a stake in 23andMe ... Fox Business